Value2Wealth Investor

CFO also starts with PBT and adjusts for non-cash items: PBT -10 Add: Depreciation 2 Working Capital Changes 0 ------------------------------- CFO -8 If a product company expenses almost all product development costs through the P&L instead of capitalizing them: Reported profit can be very low or even negative. Tax liability can be reduced or eliminated because taxable income is lower. Cash flow from operations may also appear lower than companies that capitalize development costs since it starts with PBT. However, the business may actually be generating substantial cash and choosing to aggressively reinvest it into product development. Example company A Revenue 100 Cr Other operating costs 20 Cr Product development 90 Cr ----------------------------------------- PBT -10 Cr The company A reports a loss and pays little or no income tax. But the key question is: Is the ₹90 Cr really a maintenance expense or a growth investment? For a product company, much of that spend may be creating future products, IP, patents, AI models, platforms, etc. Economically, it behaves more like an investment than a normal operating cost. Many sophisticated investors create an "economic earnings" view: Reported Profit -10 Cr Add back: Growth Product Development 70 Cr Less: Maintenance Product Development 20 Cr -------------------------------------------- Economic Profit 40 Cr ( -10 +70 -20 ) What to check If a company reports losses for years but: Revenue keeps growing Gross margins are high Customer retention is strong Cash balance keeps increasing Little debt is required then the losses may simply reflect aggressive reinvestment in product development. This type of companies can deliberately keep accounting profits near zero for many years while building valuable intellectual property and avoiding taxes through legitimate R&D spending. In fact, some of the most successful software companies historically looked barely profitable during their heavy product-building phase because they chose to expense development costs rather than maximize reported earnings. The key is determining whether the R&D spend is creating future value or simply covering ongoing operating losses.